Xponance, Inc. Amgen Inc Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Xponance, Inc. holds 118,708 shares of AMGN stock, worth $33.2 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

118,708

Previous 119,858 0.96%

Holding current value

$33.2 Million

Previous $37.4 Million 2.13%

% of portfolio

0.37%

Previous 0.39%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $355,787 - $387,987	-1,150 Reduced 0.96%	118,708 $38.2 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $1.36 Million - $1.65 Million	5,175 Added 4.51%	119,858 $37.4 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $804,727 - $971,408	2,993 Added 2.68%	114,683 $32.6 Million
Q4 2023 Jan 31, 2024	BUY	$255.7 - $288.46 $952,738 - $1.07 Million	3,726 Added 3.45%	111,690 $32.2 Million
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $208,154 - $258,429	952 Added 0.89%	107,964 $29 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $1.8 Million - $2.13 Million	-8,397 Reduced 7.28%	107,012 $23.8 Million
Q1 2023 Apr 17, 2023	BUY	$225.79 - $275.2 $559,281 - $681,670	2,477 Added 2.19%	115,409 $27.9 Million
Q4 2022 Jan 23, 2023	BUY	$229.03 - $291.01 $2.28 Million - $2.89 Million	9,938 Added 9.65%	112,932 $0
Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $1.84 Million - $2.08 Million	8,203 Added 8.65%	102,994 $23.2 Million
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $1.54 Million - $1.71 Million	-6,673 Reduced 6.58%	94,791 $23.1 Million
Q1 2022 Apr 20, 2022	BUY	$219.27 - $242.57 $28,943 - $32,019	132 Added 0.13%	101,464 $24.5 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $1.63 Million - $1.86 Million	8,189 Added 8.79%	101,332 $22.8 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $758,016 - $888,107	-3,571 Reduced 3.69%	93,143 $19.8 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $2.51 Million - $2.78 Million	-10,729 Reduced 9.99%	96,714 $23.6 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $51,926 - $60,512	-234 Reduced 0.22%	107,443 $26.7 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $28,778 - $34,270	-133 Reduced 0.12%	107,677 $24.8 Million
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $1.13 Million - $1.26 Million	-4,821 Reduced 4.28%	107,810 $27.4 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $22.3 Million - $27.3 Million	112,631 New	112,631 $26.6 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account